---
title: "TY PHAR. : Doxycycline hydrochloride tablets pass consistency evaluation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229867593.md"
description: "TY PHAR. announced that its drug Doxycycline Hydrochloride Tablets have passed the consistency evaluation, with two specifications of 0.05g and 0.1g. Doxycycline Hydrochloride Tablets are mainly used for upper respiratory tract infections, tonsillitis, biliary tract infections, lymphadenitis, cellulitis, chronic bronchitis in the elderly caused by sensitive Gram-positive cocci and Gram-negative bacilli, and are also used for typhus, scrub typhus, and mycoplasma pneumonia. Passing the consistency evaluation is beneficial for the company to participate in centralized procurement bidding, enhance product market competitiveness, and expand market share"
datetime: "2025-02-27T07:41:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229867593.md)
  - [en](https://longbridge.com/en/news/229867593.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229867593.md)
generator: "portal-rs"
---

# TY PHAR. : Doxycycline hydrochloride tablets pass consistency evaluation

TY PHAR. announced that its drug Doxycycline Hydrochloride Tablets have passed the consistency evaluation, with two specifications of 0.05g and 0.1g. Doxycycline Hydrochloride Tablets are mainly used for upper respiratory tract infections, tonsillitis, biliary tract infections, lymphadenitis, cellulitis, chronic bronchitis in the elderly, and other conditions caused by sensitive Gram-positive cocci and Gram-negative bacilli. They are also used for typhus, scrub typhus, and mycoplasma pneumonia. Passing the consistency evaluation is beneficial for the company to participate in centralized procurement bidding, enhance the market competitiveness of its products, and expand its market share

### Related Stocks

- [002728.CN](https://longbridge.com/en/quote/002728.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [FirstRand Bank lists ZAR 10 million structured product notes on JSE](https://longbridge.com/en/news/296785696.md)
- [08:36 ETUltimate Men's HQ Launches Private Product-Match Education Experience](https://longbridge.com/en/news/296789283.md)
- [09:10 ETNew CU Anschutz Division of Transplant Medicine is First of Its Kind Nationally](https://longbridge.com/en/news/296793703.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**